Therapeutic Solutions International's Subsidiary MolecuVax, Inc. to Initiate Cancer Immunotherapy Clinical Trial Aimed at Eradicating Cancer Stem Cells Using MVAX-001
April 11, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 11, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc.,...
Therapeutic Solutions International Announces the Appointment of
Dr. Hong Ma as Chief Scientific Officer
March 16, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - March 16, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) a public clinical stage company focused on immune modulation for the treatment of...
Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc.
February 08, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - February 08, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Company has licensed their Exosome Patent to MolecuVax,...
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre
January 25, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 25, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive intellectual property license agreement...
Therapeutic Solutions International Announces the Appointment of BioPharmaceutical Pioneer Thomas E. Ichim, Ph.D to Board of Directors
January 22, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 22, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the appointment of Dr. Thomas E. Ichim to our Board of Directors. Dr....
Therapeutic Solutions International Announces the Appointment of Dr. Barry Glassman to the TSI Scientific Advisory Board
January 05, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 05, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Barry Glassman, DMD, DAAPM, DAACP, FICCMO, Diplomate ABDSM,...
Therapeutic Solutions International Announces the Licensing of Probiotic Technology to OmniBiome, Inc.
December 08, 2015 08:55 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Dec 8, 2015) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed an additional Patent to OmniBiome, Inc....
Therapeutic Solutions International Files Patent on Anticancer Nanotechnology Based Immunotherapy
November 23, 2015 08:55 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Nov 23, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived...
Therapeutic Solutions International Announces the Licensing of Patents to OmniBiome and the Appointment of Iryna Dzieciuch, M.S. as Chief Executive Officer of OmniBiome
November 18, 2015 08:55 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Nov 18, 2015) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed three Patents to OmniBiome, Inc....
Therapeutic Solutions International Announces the Appointment of Michael G. Agadjanyan, Ph.D. to Company Scientific Advisory Board
October 19, 2015 08:55 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Oct 19, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Michael Agadjanyan, Ph.D. has been appointed to our Scientific...